Despoina Fotiou

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

A Phase 2 trial of daratumumab monotherapy in newly diagnosed patients with cardiac stage IIIb AL amyloidosis.

A Phase 2 trial of daratumumab monotherapy in newly diagnosed patients with cardiac stage IIIb AL amyloidosis.

Journal: Blood
Published: December 19, 2025

Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation.

Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation.

Journal: Leukemia & lymphoma
Published: September 01, 2023

Cardiac mechanics in response to proteasome inhibition: a prospective study.

Cardiac mechanics in response to proteasome inhibition: a prospective study.

Journal: European heart journal. Cardiovascular Imaging
Published: March 13, 2022

CCL3 Signaling in the Tumor Microenvironment.

CCL3 Signaling in the Tumor Microenvironment.

Journal: Advances in experimental medicine and biology
Published: February 16, 2020

Monitoring Plasma Cell Dyscrasias With Cell-free DNA Analysis.

Monitoring Plasma Cell Dyscrasias With Cell-free DNA Analysis.

Journal: Clinical lymphoma, myeloma & leukemia
Published: February 05, 2020

How I treat elderly patients with plasma cell dyscrasias.

How I treat elderly patients with plasma cell dyscrasias.

Journal: Aging
Published: November 15, 2018

Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.

Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.

Journal: Annals of hematology
Published: June 27, 2018

Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM.

Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM.

Journal: Clinical lymphoma, myeloma & leukemia
Published: May 20, 2018

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.

Journal: Annals of hematology
Published: January 25, 2018

Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases.

Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases.

Journal: Leukemia & lymphoma
Published: August 08, 2017

Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens.

Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens.

Journal: Leukemia & lymphoma
Published: December 15, 2016

Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.

Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.

Journal: Leukemia & lymphoma
Published: October 12, 2016
Showing 1-12 of 15

Last Updated: 09/26/2026